Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29188284

Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2018 Mar 1
First author
Diamond EL

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2019 Jan 1;5(1):122. doi: 10.1001/jamaoncol.2018.5678.
    note
    Source null
    related pmid
    30422161
    relationship
    Erratum in
  2. citation
    JAMA Oncol. 2019 Jan 1;5(1):118-119. doi: 10.1001/jamaoncol.2018.5674.
    note
    Source null
    related pmid
    30422162
    relationship
    Comment in

Authors and identifiers

  1. name
    Diamond EL
    type
    Author
  2. name
    Subbiah V
    type
    Author
  3. name
    Lockhart AC
    type
    Author
  4. name
    Blay JY
    type
    Author
  5. name
    Puzanov I
    type
    Author
  6. name
    Chau I
    type
    Author
  7. name
    Raje NS
    type
    Author
  8. name
    Wolf J
    type
    Author
  9. name
    Erinjeri JP
    type
    Author
  10. name
    Torrisi J
    type
    Author
  11. name
    Lacouture M
    type
    Author
  12. name
    Elez E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Diamond EL
    type
    Author
  2. name
    Subbiah V
    type
    Author
  3. name
    Lockhart AC
    type
    Author
  4. name
    Blay JY
    type
    Author
  5. name
    Puzanov I
    type
    Author
  6. name
    Chau I
    type
    Author
  7. name
    Raje NS
    type
    Author
  8. name
    Wolf J
    type
    Author
  9. name
    Erinjeri JP
    type
    Author
  10. name
    Torrisi J
    type
    Author
  11. name
    Lacouture M
    type
    Author
  12. name
    Elez E
    type
    Author
bibliography ids
  1. nci-bib-fbb72f65aff883d2b91827dc
book metadata
content sha256
28dd869d0b2ab2c1786ca568644f3df08070b5fa687899900a115991f5e4fb22
document type
citation
dois
  1. 10.1001/jamaoncol.2017.5029
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:29188284
immutable id
pubmed:29188284@28dd869d0b2ab2c1786ca568644f3df08070b5fa687899900a115991f5e4fb22
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
3
name
JAMA oncology
nlm unique id
101652861
pages
384-388
volume
4
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2019 Jan 1;5(1):122. doi: 10.1001/jamaoncol.2018.5678.
    note
    Source null
    related pmid
    30422161
    relationship
    Erratum in
  2. citation
    JAMA Oncol. 2019 Jan 1;5(1):118-119. doi: 10.1001/jamaoncol.2018.5674.
    note
    Source null
    related pmid
    30422162
    relationship
    Comment in
outcomes validated
false
pmid
29188284
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
54d0496fc1a1b2a69291e18c020b4a99701ccf48948880cac97f07b6544e1f82
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2018 Mar 1
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29188284/
title
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.

Preserved source evidence · Not medical advice